Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CD34+ Stem Cells for Liver Insufficiency
NCT00655707Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Jan 2006
- Primary completion
- Apr 2009
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous CD34+ hematopoietic stem cells in Chronic liver insufficiency (CLD), sponsored by Imperial College London. Started Jan 2006; status: completed.
02
Drugs
autologous CD34+ hematopoietic stem cells
03
Conditions
Chronic liver insufficiency (CLD)
Beyond the preview
Go deeper on NCT00655707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655707.